The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.
Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...
Celltrion Inc., a major South Korean biopharmaceutical firm, said Friday its new biosimilar for an autoimmune disease treatment has received approval from the U.S. Food and Drug Administration (FDA).